logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12403114 B1

PDFFull Text
Date of Patent:
Sep. 02, 2025

Filed:

Mar. 12, 2020

Cannabinoid acid ester compositions and uses thereof

Applicants:

Epm (Ip), Inc., San Francisco, CA (US);

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, Jerusalem, IL;

Inventors:

Dror Robinson, San Francisco, CA (US);

Dan Peer, San Francisco, CA (US);

Joseph Tam, Jerusalem, IL;

Raphael Mechoulam, Jerusalem, IL;

Assignees:

EPM (IP), INC.;

YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD, Jerusalem, IL;

Attorney:

Dorsey & Whitney LLP

Primary Examiner:

Juliet C Switzer

Assistant Examiner:

Dawanna Shar-Day undefined White

Int. Cl.
CPC ...
A61K 31/216 (2006.01); A61K 31/352 (2006.01); A61K 36/185 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01); A61K 47/24 (2006.01); A61K 47/40 (2006.01); A61P 1/00 (2006.01); A61P 1/16 (2006.01); A61P 3/00 (2006.01); A61P 3/04 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 13/12 (2006.01); A61P 15/00 (2006.01); A61P 17/00 (2006.01); A61P 19/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/216 (2013.01); A61K 31/352 (2013.01); A61K 36/185 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/24 (2013.01); A61K 47/40 (2013.01); A61P 1/00 (2018.01); A61P 1/16 (2018.01); A61P 3/00 (2018.01); A61P 3/04 (2018.01); A61P 3/06 (2018.01); A61P 3/10 (2018.01); A61P 13/12 (2018.01); A61P 15/00 (2018.01); A61P 17/00 (2018.01); A61P 19/02 (2018.01);
Abstract

The present disclosure provides pharmaceutical compositions including a cannabinoid acid ester compound alone or in combination with one or more additional cannabinoid compounds. In some embodiments, the cannabinoid acid ester compound is a cannabidiolic acid ester. A variety of therapeutic applications in which the cannabinoid acid ester compounds and pharmaceutical compositions find use are also provided, including combination therapies using cannabinoid acid ester compounds and one or more additional therapeutic agents.

Find Patent Forward Citations

Loading…